Friday 6-20-2014 Celgene Corp (CELG) $CELG opened at 169.70 hitting the high price of 172.40 and a day low of 166.32 with a total volume of 7,432,777. CELG had a previous close of 168.31 and has been seeing an average volume of 2,455,150.
Overall Average: 88% Buy
Recent stock forum discussions about CELG http://investorshangout.com/search?q=CELG&...mp;yt0=Go!
Celgene Sees Better Results For Psoriatic Arthritis
at Investor's Business Daily - Fri Jun 20, 5:12PM CDT
When a large biotechnology company has a wonder drug, it makes sense to see if the product can treat multiple diseases. Celgene (CELG) has done well in this regard. In January, Celgene's key drug Abraxane won approval in Europe for use in combination... (full story)
Final Glance: Biotechnology companies
AP - Fri Jun 20, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading: (full story)
Stocks Hold Slim Gains; Celgene, Salix Rally
at Investor's Business Daily - Fri Jun 20, 2:02PM CDT
The major stock indexes continued to trade modestly higher late Friday and were on pace to end the week with gains of more than 1%. The Dow Jones industrial average rose 0.2%. The broader Nasdaq and the S&P 500 edged up 0.1% each. Amid quadruple... (full story)
Celgene (CELG) Approaches New Upside Target of $171.95
Comtex SmarTrend(R) - Fri Jun 20, 12:28PM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $166.67 today and has reached the first level of resistance at $170.13. Investors may be interested in a cross of the next upside pivot targets of $171.95 and $177.23. (full story)
Midday Glance: Biotechnology companies
AP - Fri Jun 20, 12:26PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.: (full story)
Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split. (full story)
Early Glance: Biotechnology companies
AP - Fri Jun 20, 9:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)
Shares of CELG Up 12.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 20, 9:33AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $147.87. In approximately 2 months, Celgene has returned 12.94% as of today's recent price of $167.00. (full story)
Company News for June 20, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 9:06AM CDT
Companies in the News are: BBRY,RAD,CELG,KR (full story)
Celgene's stockholders authorises two-for-one common stock split
M2 - Fri Jun 20, 5:39AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) said on Thursday that its stockholders have approved a two-for-one stock split of its common stock at its Annual Meeting of Stockholders held on 18 June 2014. (full story)
'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM. (full story)
'Fast Money' Recap: Late-Day Rally, Another Record High
at The Street - Fri Jun 20, 4:00AM CDT
The trading panel looked at gold and oil as the S&P hit another record high. (full story)
Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact. (full story)
Celgene Set to Possibly Pullback After Yesterday's Rally of 4.49%
Comtex SmarTrend(R) - Thu Jun 19, 3:41PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)
After Yesterday's Rally of 4.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jun 19, 3:40PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)
Stocks On Track To End Win Streak; Oracle Reports After Close
at Investor's Business Daily - Thu Jun 19, 1:59PM CDT
Stocks were off their session lows in late trading Thursday but were still poised to snap a four-session win streak. The Nasdaq was off by 0.3%, while the S&P 500 slipped 0.1%. They had been down as much as 0.5% and 0.2%, respectively. The Dow Jones... (full story)
Today's Top Performers In Health Care
at The Street - Thu Jun 19, 12:04PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today. (full story)
Overall Average: 88% Buy
Recent stock forum discussions about CELG http://investorshangout.com/search?q=CELG&...mp;yt0=Go!
Celgene Sees Better Results For Psoriatic Arthritis
at Investor's Business Daily - Fri Jun 20, 5:12PM CDT
When a large biotechnology company has a wonder drug, it makes sense to see if the product can treat multiple diseases. Celgene (CELG) has done well in this regard. In January, Celgene's key drug Abraxane won approval in Europe for use in combination... (full story)
Final Glance: Biotechnology companies
AP - Fri Jun 20, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading: (full story)
Stocks Hold Slim Gains; Celgene, Salix Rally
at Investor's Business Daily - Fri Jun 20, 2:02PM CDT
The major stock indexes continued to trade modestly higher late Friday and were on pace to end the week with gains of more than 1%. The Dow Jones industrial average rose 0.2%. The broader Nasdaq and the S&P 500 edged up 0.1% each. Amid quadruple... (full story)
Celgene (CELG) Approaches New Upside Target of $171.95
Comtex SmarTrend(R) - Fri Jun 20, 12:28PM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $166.67 today and has reached the first level of resistance at $170.13. Investors may be interested in a cross of the next upside pivot targets of $171.95 and $177.23. (full story)
Midday Glance: Biotechnology companies
AP - Fri Jun 20, 12:26PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.: (full story)
Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split. (full story)
Early Glance: Biotechnology companies
AP - Fri Jun 20, 9:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)
Shares of CELG Up 12.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 20, 9:33AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $147.87. In approximately 2 months, Celgene has returned 12.94% as of today's recent price of $167.00. (full story)
Company News for June 20, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 9:06AM CDT
Companies in the News are: BBRY,RAD,CELG,KR (full story)
Celgene's stockholders authorises two-for-one common stock split
M2 - Fri Jun 20, 5:39AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) said on Thursday that its stockholders have approved a two-for-one stock split of its common stock at its Annual Meeting of Stockholders held on 18 June 2014. (full story)
'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM. (full story)
'Fast Money' Recap: Late-Day Rally, Another Record High
at The Street - Fri Jun 20, 4:00AM CDT
The trading panel looked at gold and oil as the S&P hit another record high. (full story)
Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact. (full story)
Celgene Set to Possibly Pullback After Yesterday's Rally of 4.49%
Comtex SmarTrend(R) - Thu Jun 19, 3:41PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)
After Yesterday's Rally of 4.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jun 19, 3:40PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)
Stocks On Track To End Win Streak; Oracle Reports After Close
at Investor's Business Daily - Thu Jun 19, 1:59PM CDT
Stocks were off their session lows in late trading Thursday but were still poised to snap a four-session win streak. The Nasdaq was off by 0.3%, while the S&P 500 slipped 0.1%. They had been down as much as 0.5% and 0.2%, respectively. The Dow Jones... (full story)
Today's Top Performers In Health Care
at The Street - Thu Jun 19, 12:04PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today. (full story)
